S-1/A: CONX Corp Files Amendment No. 3 to Form S-1, Registers Shares for Warrant Exercise and Resale

CONX Corp has filed an amendment to its Form S-1 registration statement to register shares of Class A common stock issuable upon warrant exercise and for resale by selling securityholders.

Summary

• CONX Corp has filed an Amendment No. 3 to Form S-1 to register 30,083,285 shares of Class A Common Stock issuable upon the exercise of warrants.
• The filing also covers the offer and resale of 30,000 shares of Class A Common Stock by selling securityholders, specifically independent directors.
• The company will receive proceeds only from the exercise of warrants, potentially up to $346.0 million, but not from the sale of shares by the selling securityholders.
• If the Class A Common Stock price remains below $11.50, warrant holders are unlikely to exercise their warrants for cash, resulting in little or no cash proceeds to CONX.
• The Private Placement Warrants may be exercised on a cashless basis by nXgen Opportunities LLC or its transferees, potentially diluting the value of Class A Common Stock.
• The registered shares represent a significant portion of the outstanding Class A Common Stock, potentially leading to substantial dilution and a decline in the public trading price.
• Certain existing stockholders, including nXgen and certain of the Selling Securityholders, purchased, or may purchase, securities in the Company at a price below the current trading price of such securities, and may experience a positive rate of return based on the current trading price.
• Future investors in the Company may not experience a similar rate of return.
• Charles W. Ergen, through nXgen, beneficially owns approximately 99.4% of CONX's Class A Common Stock and may exert substantial influence on actions requiring a stockholder vote.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While there's potential for capital from warrant exercises, the low stock price, potential dilution, and Nasdaq delisting raise concerns. The controlling influence of nXgen also adds uncertainty.

Positives

• Potential for CONX to receive up to $346.0 million from warrant exercises, providing capital for general corporate and working capital purposes.

Negatives

• Low Class A Common Stock price ($4.40 on July 31, 2024) makes cash exercise of warrants unlikely.
• Potential for significant dilution due to the large number of shares being registered.
• nXgen's controlling stake (99.4%) could lead to decisions not in the best interest of other stockholders.
• Delisting from Nasdaq has limited investors' ability to make transactions in CONX securities.

Risks

• Dependence on a single tenant (Seller) for substantially all revenues.
• Limited experience in operating commercial real estate.
• Potential inability to obtain additional financing.
• Risk of being deemed an investment company.
• Conflicts of interest due to officers' and directors' affiliations with other entities like DISH and EchoStar.
• Delisting from Nasdaq has limited investors' ability to make transactions in CONX securities.
• Limited number of outstanding Class A Common Stock not held by nXgen could result in continued volatility of stock price.

Future Outlook

The company anticipates growth through further acquisition opportunities, including disruptive technologies and additional infrastructure assets, and seeks to diversify operations beyond real estate into the communications and connectivity sectors.

Industry Context

The document indicates that the company faces competition from other landlords, REITs, investment companies, pension funds, private equity and hedge fund investors, sovereign funds, healthcare operators, lenders, developers and other institutional investors, some of whom may have greater resources and lower costs of capital than it does.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or comparable companies.
• However, it mentions competition from REITs, investment companies, and other institutional investors, suggesting that CONX operates in a competitive landscape where access to capital and operational efficiency are crucial.

Related Party Transactions

• Charles W. Ergen, through nXgen, beneficially owns approximately 99.4% of CONX's Class A Common Stock and may exert substantial influence on actions requiring a stockholder vote.
• Our Chief Executive Officer, Jason Kiser served as Treasurer of DISH from 2008 to 2023, and has been employed by entities owned or controlled by Mr. Ergen for over 35 years.
• The Independent Directors acquired their shares of Class A Common Stock offered hereby at no cost in exchange for services rendered to the Company.

Stakeholder Impact

• Public securityholders may not be able to experience the same positive rates of return on securities they purchase because the Independent Directors received shares of Class A Common Stock at no cost.
• The concentrated control of nXgen could also discourage potential investors from acquiring our Class A Common Stock.

Next Steps

• The company will use commercially reasonable efforts to maintain the effectiveness of the registration statement for the Class A Common Stock issuable upon exercise of the warrants.
• The company intends to grow through further acquisition opportunities, including, but not limited to, disruptive technologies and infrastructure assets.

Key Dates

Keywords

Class A Common Stock, Warrants, Registration Statement, Selling Securityholders, Dilution, Private Placement, Business Combination, CONX Corp, nXgen, Ergen, OTC, Delisting